Combatting drug resistance for melanoma patients
Monday, June 30, 2014 - 20:01
in Health & Medicine
A new way to identify possible therapeutic targets for patients with drug resistant melanoma has been developed by researchers. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.